Rare diseases
Investigational molecules
Locations
1 Glaukos Way, 92656-2704, United States
Glaukos Corp. focuses on clinical research in persistent corneal epithelial defects, with attention to therapies intended to support corneal re-epithelialization and restore the integrity of the ocular surface.
Its research activity is centered on ophthalmic treatment development for conditions where the cornea fails to heal normally, reflecting a narrow therapeutic emphasis within eye disease.
Glaukos Corp. runs clinical trials in conditions such as Persistent corneal epithelial defect, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
